2-Trifluoromethoxy-4-methoxybenzaldehyde, 95.0%, 5g

1-Chloro-3-fluorobenzene>97.0%(GC)25g

1-Benzyl-3-isopropyl-piperidin-4-one, 98%, 5g

1-Phenylcyclopropane-1-sulfonamide, 98%, 250mg

(R)-2,3-Dihydro-benzo[1,4]dioxine-2-carboxylic acid, 98.0%, 5g

Ethyl-8-bromooctanoate, 95.0%, 10g

(METHOXYCARBONYL)-D-PHENYLALANINE, 95.0%, 1g

2,2-Dimethyl-1,3-dioxane-4,6-dione, 98.0%, 250g

4-(4-(2-Hydroxyethyl)piperazin-1-yl)butane-1-sulfonic acid, 95.0%, 500g

CIS-4,7,10,13,16,19-DOCOSAHEXAENOIC ACID ETHYL ESTER, 95%, 1g

7-FLUORO-6-METHOXYISOINDOLIN-1-ONE, 95.0%, 100mg

GC capillary column ROTI®Cap-5 MS, 25 m, 0.20 mm, 0.20 µm, 1 Piece(s)

tert-Butyl (4R-cis)-6-[(acetyloxy)methyl]-2,2-dimethyl-1,3-dioxane-4-acetate, 95.0%, 25g